IL-1A
Interleukin, NYU to Commercialize IL-1 Genetic Test for Osteoarthritis Progression
The agreement is based on a jointly owned US patent application that claims methods of assessing a person's risk for generalized osteoarthritis based on IL-1 genotypes.
This article has been updated from an earlier version with additional comments from Eliot Lurier.
By Turna Ray